SR 8890
Alternative Names: SoRI 8890Latest Information Update: 15 Jun 2001
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Southern Research Institute
- Class Antibacterials
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycobacterium avium complex infections
Most Recent Events
- 15 Jun 2001 No-Development-Reported for Mycobacterium avium complex infections in USA (Unknown route)
- 15 Jan 1999 New profile
- 15 Jan 1999 Preclinical development for Mycobacterium avium complex infections in USA (Unknown route)